Skanska's Recent Achievements in Biotechnology Construction
Skanska has recently signed a significant contract with the University of Virginia focused on the construction of an expansive biotechnology facility. This new agreement for the Paul and Diane Manning Institute of Biotechnology is valued at USD 116 million, nearly SEK 1.2 billion. This addition will be accounted for in Skanska's order bookings for the upcoming third quarter.
Details of the Paul and Diane Manning Institute
This state-of-the-art facility will span five stories and approximately 33,000 square meters, equating to about 354,000 square feet. The Paul and Diane Manning Institute will host a pioneering translational research program unique to its region. Designed to promote collaboration and innovation, the building will boast modular lab spaces and versatile support areas that can accommodate 100 to 150 researchers and numerous partnering biotechnology firms.
Enhanced Research Capabilities
Equipped with advanced research facilities and core services, the institute is expected to significantly advance scientific exploration and technological development. As a result, it promises to be a hub for cutting-edge research, drawing upon both local insights and global expertise.
Construction Timeline and Future Prospects
Construction commenced recently, with plans set for completion in the final quarter of 2027. This projected timeline not only reflects Skanska’s commitment to quality but also their expertise in managing extensive construction projects within the biotechnology sector.
Company’s Commitment to Sustainable Development
Skanska is dedicated to promoting sustainable construction practices. By integrating eco-friendly solutions, they strive to minimize the environmental impact associated with building new facilities such as this one. Their ongoing initiatives highlight a commitment to sustainability that resonates through various aspects of their operations.
Community Impact and Engagement
In addition to advancing scientific research, the institute aims to strengthen ties with the surrounding community. Skanska's projects often include community engagement initiatives, ensuring that local residents and stakeholders are involved in the development process. Such efforts not only promote transparency but also foster a sense of shared ownership and pride within the community.
Contact Information
For additional information regarding this project, please reach out to Ashley Jeffery, Communications Director at Skanska Group, via phone at +1 813 459 3682. For media inquiries, Andreas Joons, Press Officer at Skanska Group, can be reached at +46 (0)10 449 04 94 or through the dedicated media line at +46 (0)10 448 88 99.
Frequently Asked Questions
What is the purpose of the Paul and Diane Manning Institute?
The institute will facilitate a translational research program aimed at pioneering biotech advancements.
How much is Skanska investing in the construction?
Skanska has signed a contract worth USD 116 million for this construction project.
When will construction be completed?
The facility is expected to be finished by the fourth quarter of 2027.
Who will benefit from the new biotechnology facility?
The facility will support 100-150 researchers and collaborating biotechnology companies.
Is Skanska involved in sustainable construction?
Yes, Skanska emphasizes sustainability in their construction practices to minimize environmental impact.
